Abstract

Simple SummaryTumor budding is a histopathologic characteristic which has led to a growing interest in the prognosis prediction of cancers of various sites. We aimed to evaluate whether imaging biomarkers could predict tumor budding status. Preoperative MRI radiomic features were used as imaging biomarkers. Four machine learning classifiers were applied to build prediction models using a training dataset. Internal validation was performed to validate the built models. As a result, radiomics-based models predicted tumor budding status with a mean area under the receiver operating characteristic value of 0.816 and a mean accuracy of 0.779 in the independent test dataset. Final selected features were mostly from filtered images, implying the importance of filtering methods in radiomics. Preoperative prediction of tumor budding status may help personalize treatment in cervical cancer patients.Background: Our previous study demonstrated that tumor budding (TB) status was associated with inferior overall survival in cervical cancer. The purpose of this study is to evaluate whether radiomic features can predict TB status in cervical cancer patients. Methods: Seventy-four patients with cervical cancer who underwent preoperative MRI and radical hysterectomy from 2011 to 2015 at our institution were enrolled. The patients were randomly allocated to the training dataset (n = 48) and test dataset (n = 26). Tumors were segmented on axial gadolinium-enhanced T1- and T2-weighted images. A total of 2074 radiomic features were extracted. Four machine learning classifiers, including logistic regression (LR), random forest (RF), support vector machine (SVM), and neural network (NN), were used. The trained models were validated on the test dataset. Results: Twenty radiomic features were selected; all were features from filtered-images and 85% were texture-related features. The area under the curve values and accuracy of the models by LR, RF, SVM and NN were 0.742 and 0.769, 0.782 and 0.731, 0.849 and 0.885, and 0.891 and 0.731, respectively, in the test dataset. Conclusion: MRI-based radiomic features could predict TB status in patients with cervical cancer.

Highlights

  • Precision medicine refers to medicine optimized to the genotypic and phenotypic characteristics of an individual and disease

  • We reviewed the clinicopathologic information from the archives of medical records and corresponding hematoxylin and eosin (H&E)-stained slides of cervical cancers

  • The tumor budding (TB) status was binarily classified with a cutoff value of 4

Read more

Summary

Introduction

Precision medicine refers to medicine optimized to the genotypic and phenotypic characteristics of an individual and disease. The growing focus on precision medicine in oncologic fields is leading to an increased demand for predictable biomarkers, which can be used in decision making in clinical practice. Omics includes various research fields, including genomics, transcriptomics, proteomics, phenomics and radiomics. Because such omics fields can interact with each other in the body, it is necessary to find an association between the different research fields in order to comprehensively improve the understanding of tumor biology and their clinical behavior. Our previous study demonstrated that tumor budding (TB) status was associated with inferior overall survival in cervical cancer. The purpose of this study is to evaluate whether radiomic features can predict TB status in cervical cancer patients. The trained models were validated on the test dataset. The area under the curve values and accuracy of the models by LR, RF, SVM and NN were

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.